New Phase 1 clinical trials: 5,278 posted since Nov 2024

Name: New Phase 1 clinical trials
Creator: SpecStream
License: https://creativecommons.org/licenses/by/4.0/

The full list. New Phase 1 clinical trials: 5,278 rows for $132.78, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 222 rows a month. The new rows come each week by email, $19 a month.

Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, enrollment type, location countries and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.

For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/phase/phase-1, and every list with its row count and price is at https://specstream.ai/data/lists.json.

Updated November 9, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).

5,278 clinical studies in phase 1 were first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026; 3,570 have an industry sponsor and 3,385 are recruiting or about to. The newest, NCT07926893, was posted on November 9, 2026: Lenalidomide and Cosibelimab for the Treatment of Relapsed/Refractory Mycosis Fungoides or Sézary Syndrome (City of Hope Medical Center).

The request: Every new Phase 1 clinical trials on ClinicalTrials.gov, with the sponsor, conditions, sites and the listed contact. $10 of credit on sign-up, no card.

Get new trials like these Watch a sponsor

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

5,278New trials
3,570Industry sponsored
3,385Recruiting or not yet
November 9, 2026Latest posted

Newest trials

The newest 100 of 5,278, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

First posted	NCT ID	Title	Sponsor	Phase	Status	Conditions	Enrollment	Countries	Source
November 9, 2026	NCT07926893	Lenalidomide and Cosibelimab for the Treatment of Relapsed/Refractory Mycosis Fungoides or Sézary Syndrome	City of Hope Medical Center	Phase 1	Not yet recruiting	Recurrent Mycosis Fungoides, Recurrent Sezary Syndrome, Recurrent Transformed Mycosis Fungoides, Refractory Mycosis...	14	United States	clinicaltrials.gov
November 9, 2026	NCT07926737	CMT-133 in Healthy Adult Participants	Clement Therapeutics, Inc.	Phase 1	Not yet recruiting	Healthy Adult Participants	64		clinicaltrials.gov
November 9, 2026	NCT07926334	A Study of BI 4015092, Alone or in Combination With Other Cancer Treatment, in Patients With Advanced Cancer That Has a KRAS G12D Mutation	Boehringer Ingelheim	Phase 1	Not yet recruiting	Advanced or Metastatic Solid Tumors With KRAS G12D Mutation	200	Australia, Japan, South Korea, Spain, United States	clinicaltrials.gov
November 9, 2026	NCT07925983	A Study to Assess How Intravenous and Subcutaneous Administrations of Trosunilimab Move Through the Body of Healthy Adult Participants	AbbVie	Phase 1	Recruiting	Healthy Volunteer	60	United States	clinicaltrials.gov
November 9, 2026	NCT07925775	Immunogenicity and Safety of SYS6057 in the Participants Aged 18 Years and Above	CSPC Megalith Biopharmaceutical Co.,Ltd.	Phase 1	Not yet recruiting	Lower Respiratory Tract Disease Caused by RSV Infection	96		clinicaltrials.gov
November 9, 2026	NCT07925476	EvoXRare AI-Assisted Interpretation of Emergency Chest Radiographs	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	Phase 1	Not yet recruiting	Emergency and Critical Care, Chest Radiography, Diagnostic Error, Thoracic Abnormalities	70,000		clinicaltrials.gov
November 9, 2026	NCT07925216	A Pharmacokinetic Study of Budesonide Delayed Release Tablet D23A (D23) in Healthy Chinese Participants Under Fasting Conditions	Triastek, lnc.	Phase 1	Active not recruiting	IgA Nephropathy (IgAN)	18	China	clinicaltrials.gov
November 9, 2026	NCT07924930	A Study of Tersolisib (LY4064809) in Participants With Kidney Impairment Compared With Participants With Normal Kidney Function	Scorpion Therapeutics, a wholly owned subsidiary of Eli Lilly and Company	Phase 1	Not yet recruiting	Renal Insufficiency, Healthy Participant	32	United States	clinicaltrials.gov
November 9, 2026	NCT07924761	A Study to Investigate the Effect of Injection Site and Ethnicity on KAI-4729 Pharmacokinetics in Non-Asian and Asian Participants Living...	Kailera	Phase 1	Not yet recruiting	Overweight or Obesity	60	United States	clinicaltrials.gov
November 9, 2026	NCT07924397	A Study to Assess IG001643 in Healthy Participants	Iongen Therapeutics Co., Ltd.	Phase 1	Not yet recruiting	Pain Management	86	New Zealand	clinicaltrials.gov
November 9, 2026	NCT07924267	A Single Ascending Dose and Multiple Ascending Dose Trial to Assess the Dose, the Efficacy and Oro-sensitivity of Two Modified Linoleic...	EktaH	Phase 1	Completed	Obesity & Overweight, Overweight (BMI > 30)	120	Tunisia	clinicaltrials.gov
November 6, 2026	NCT07923747	An Ascending Dose Study of DKB903 in Participants With Rheumatoid Arthritis (RA) and Participants With Systemic Lupus Erythematosus (SLE)	Novartis Pharmaceuticals	Phase 1	Not yet recruiting	Rheumatoid Arthritis and Systemic Lupus Erythematosus	90		clinicaltrials.gov
November 6, 2026	NCT07923578	Pharmacokinetics, Safety and Tolerability of Single Sequential and Multiple Intravenous Infusions of Ulinastatin for Injection in Healthy...	Techpool Bio-Pharma Co., Ltd.	Phase 1	Not yet recruiting	Healthy Participants, Ulinastatin	40	China	clinicaltrials.gov
November 6, 2026	NCT07923487	Pilot Safety and Exploratory Efficacy of PSC-05 for the Treatment of Chronic Mild Traumatic Brain Injury	Personalized Stem Cells, Inc.	Phase 1	Enrolling by invitation	Mild Traumatic Brain Injury	10	United States	clinicaltrials.gov
November 6, 2026	NCT07923396	GK01 Cell Therapy in Gastric Cancer With Peritoneal Metastasis	Ruijin Hospital	Phase 1	Not yet recruiting	Gastric Cancer (GC)	10	China	clinicaltrials.gov
November 6, 2026	NCT07923383	An Open-label, DDI Study to Investigate the Effects of Duvakitug on the PK of Selected Cytochrome P450 Substrates	Sanofi	Phase 1	Not yet recruiting	Ulcerative Colitis, Crohn's Disease	25		clinicaltrials.gov
November 6, 2026	NCT07923214	A Phase I Study of CG-7321 Monotherapy or Combination Therapy in Advanced Solid Tumors	Chengdu Cynogen Bio-pharmaceutical Tech. Co., Ltd.	Phase 1	Recruiting	Advanced Solid Tumors, Breast Cancer, Ovarian Cancer, Gastric Cancer, Other Solid Tumors	30	China	clinicaltrials.gov
November 6, 2026	NCT07923097	Study Designed to Evaluate the Safety, Tolerability, and PK of RAP-219 Formulated as an Long Acting Injectable.	Rapport Therapeutics Inc.	Phase 1	Recruiting	Epilepsy	60	Australia	clinicaltrials.gov
November 6, 2026	NCT07923071	A Study to Assess the Pharmacokinetics and Safety of Revumenib in Participants With Advanced Cancer and Hepatic or Renal Impairment	Syndax Pharmaceuticals	Phase 1	Not yet recruiting	Relapsed/Refractory (R/R) Hematologic Malignancies, Acute Leukemia, Refractory Leukemia, Relapsed Leukemia	18		clinicaltrials.gov
November 6, 2026	NCT07922798	A Phase I Clinical Trial of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effect of UBT48128 Tablets in Healthy...	The United Bio-Technology (Hengqin) Co., Ltd.	Phase 1	Not yet recruiting	Overweight , Obesity	60	China	clinicaltrials.gov
November 6, 2026	NCT07922564	An Open-label, Randomized, Single Oral Dose, Two-period, Two-sequence, Two-way, Crossover Bioequivalence Study on Healthy Adult Male...	Zi Diligence Biocenter	Phase 1	Completed	Bioequivalence, Male	30	Egypt	clinicaltrials.gov
November 6, 2026	NCT07922538	Human Bioequivalence Study of Letermovir Tablets	The Affiliated Hospital of Qingdao University	Phase 1	Completed	Tmax*(h), Cmax(ng/mL), AUC0-t(ng∙h/mL), AUC0-∞(ng∙h/mL), λz(h-1), AUC_%Extrap(%)	56	China	clinicaltrials.gov
November 6, 2026	NCT07922174	A Clinical Trial of MK-6916 in Participants With Moderate and Severe Kidney Disease Compared to Healthy Controls (MK-6916-013)	Merck Sharp & Dohme LLC	Phase 1	Not yet recruiting	Healthy, Renal Impairment	32		clinicaltrials.gov
November 6, 2026	NCT07922096	A First-in-human Study of SMP-656 in Subjects With Locally Advanced/ Metastatic HER2 Expressing or Mutated Solid Tumors	Chengdu SciMount Pharmatech Co., Ltd.	Phase 1	Completed	HER2-Expressing Advanced Solid Tumors, HER2-Mutated Advanced Solid Tumors, Metastatic Solid Tumors	35	China	clinicaltrials.gov
November 6, 2026	NCT07922070	A Bioequivalence Study of Olanzapine Samidofen Tablets in Healthy Subjects Under Fasting Conditions.	The Affiliated Hospital of Qingdao University	Phase 1	Completed	Bipolar I Disorder	36	China	clinicaltrials.gov
November 6, 2026	NCT07921966	Pharmacokinetics and Relative Bioavailability of Intranasal vs Intramuscular Olanzapine in Healthy Adult Participants	Neurelis, Inc.	Phase 1	Not yet recruiting	Healthy Adult Participants	24		clinicaltrials.gov
November 6, 2026	NCT07921316	Comparing the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administered Using Two Subcutaneous...	Amgen	Phase 1	Not yet recruiting	Obesity, Overweight	356		clinicaltrials.gov
November 6, 2026	NCT07920861	A Study of HB0017 Injection in Healthy Volunteers to Evaluate Safety and Tolerability of a Single Subcutaneous Injection in Low-Body-Weight...	Huabo Biopharm Co., Ltd.	Phase 1	Recruiting	Psoriasis, Ankylosing Spondylitis	90	China	clinicaltrials.gov
November 6, 2026	NCT07920822	Evaluation of the I-phase Clinical Trial of 177Lu-HX02 Injection in Patients With Advanced Malignant Solid Tumors	Hexin (Suzhou) Pharmaceutical Technology Co., Ltd	Phase 1	Enrolling by invitation	Soft Tissue Sarcoma, Non-small Cell Lung Cancer	12	China	clinicaltrials.gov
November 6, 2026	NCT07920809	A Study of HSK60002 Tablets in Participants With Moderate-to-Severe Atopic Dermatitis	Haisco Pharmaceutical Group Co., Ltd.	Phase 1	Not yet recruiting	Dermatitis Atopic	60		clinicaltrials.gov
November 6, 2026	NCT07920783	A Phase I Study of GLR2053 Tablets in Chinese Healthy Adult Participants	Gan & Lee Pharmaceuticals.	Phase 1	Not yet recruiting	Atopic Dermatitis	124	China	clinicaltrials.gov
November 5, 2026	NCT07919509	A Project Assessing the Safety and Feasibility of Using Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Ovarian Cancer During...	University of Alabama at Birmingham	Phase 1	Not yet recruiting	Cancer, Chemotherapy, Squamous Cell Carcinoma (SCC)	6	United States	clinicaltrials.gov
November 5, 2026	NCT07919314	A Study to Evaluate the Effects of Therapeutic and Supratherapeutic Doses of KRP-S124 Compared to Placebo With Moxifloxacin on QTc Interval...	Kyorin Pharmaceutical Co.,Ltd	Phase 1	Recruiting	Healthy Participants	40	Canada	clinicaltrials.gov
November 5, 2026	NCT07919210	A Study to Investigate the Safety, Reactogenicity, and Immunogenicity of a Preventative Vaccine for Marburg Virus (mRNA-1519) in Healthy...	ModernaTX, Inc.	Phase 1	Not yet recruiting	Marburg Virus Disease (MVD)	64	United Kingdom	clinicaltrials.gov
November 5, 2026	NCT07919197	A Study to Investigate the Safety and Immunogenicity of mRNA-1469 in African Participants 1 to 65 Years of Age	ModernaTX, Inc.	Phase 1	Not yet recruiting	Ebola-Bundibugyo Virus Disease (Ebola-BDBV)	224	Uganda	clinicaltrials.gov
November 5, 2026	NCT07919028	A Clinical Trial of MK-7602 in Healthy Volunteers (MK-7602-006)	Merck Sharp & Dohme LLC	Phase 1	Not yet recruiting	Healthy	24		clinicaltrials.gov
November 5, 2026	NCT07918898	Comparison of Pharmacokinetic/Pharmacodynamic Characteristics and Safety of GZR101-80 Injection With Separately Injected, Simultaneous...	Gan & Lee Pharmaceuticals.	Phase 1	Not yet recruiting	Healthy Participants	26		clinicaltrials.gov
November 5, 2026	NCT07918859	A Study of Imlunestrant (LY3484356) in Healthy Female Participants	Eli Lilly and Company	Phase 1	Not yet recruiting	Healthy	343	United States	clinicaltrials.gov
November 5, 2026	NCT07918469	A Clinical Study to Assess the Safety, Tolerability and Pharmacokinetics of Orally Administered Cannabidiol Capsules (AVAT-121) and...	Avata Biosciences Holdings Ltd	Phase 1	Not yet recruiting	Focal Onset Seizure	44		clinicaltrials.gov
November 5, 2026	NCT07918456	A Phase I Clinical Trial of CPU-YL01 Injection in Patients With Chronic Hepatitis B.	Jiangsu Chuangyuan Life Science and Technology Co., Ltd.	Phase 1	Enrolling by invitation	Chronic Hepatitis B	74	China	clinicaltrials.gov
November 5, 2026	NCT07918404	Safety and Tolerability of Fluticasone Propionate 10% Nasal Insert in Participants With Chronic Allergic Rhinitis	Dianosic	Phase 1	Not yet recruiting	Chronic Allergic Rhinitis	25		clinicaltrials.gov
November 4, 2026	NCT07917598	TEA Synchronized With Natural Breathing for EPS	MetroHealth Medical Center	Phase 1	Not yet recruiting	Epigastric Pain Syndrome	40	United States	clinicaltrials.gov
November 4, 2026	NCT07916961	Study of AB-110 in Healthy and Hypertensive Participants	Antlia Bioscience, Inc	Phase 1	Not yet recruiting	Hypertension (HTN), Healthy Adult Participants	104	New Zealand	clinicaltrials.gov
November 4, 2026	NCT07916194	A Study of Zovaglutide (ZT002 Injection) in Participants With Hepatic Impairment and Healthy Participants	Beijing QL Biopharmaceutical Co.,Ltd	Phase 1	Not yet recruiting	Overweight, Obesity	24	China	clinicaltrials.gov
November 4, 2026	NCT07916181	A Study to Test the Safety of the Study Drug Fosmanogepix and How the Body Handles It in Adults With Severe Kidney Failure on Dialysis	Basilea Pharmaceutica	Phase 1	Recruiting	End Stage Renal Disease on Dialysis, Adult	20	United States	clinicaltrials.gov
November 4, 2026	NCT07915986	Brain Dopamine Dynamics in Obesity	Yale University	Phase 1	Not yet recruiting	Obesity	100	United States	clinicaltrials.gov
November 4, 2026	NCT07915947	LTG-321 - Itraconazole Drug-drug Interaction (DDI) Study	Latigo Biotherapeutics	Phase 1	Not yet recruiting	PK Drug-drug Interaction Study	28		clinicaltrials.gov
November 4, 2026	NCT07915856	A Study of QLS5314 Monotherapy in Participants With Advanced Solid Tumors	Shanghai Qilu Pharmaceutical Research and Development Center LTD	Phase 1	Not yet recruiting	Advanced Solid Tumors	70		clinicaltrials.gov
November 4, 2026	NCT07915544	A Study of GKL-006Allo Injection in Patients With Ankylosing Spondylitis	Beijing Gene Key Life Technology Co., Ltd	Phase 1	Not yet recruiting	Ankylosing Spondylitis	12	China	clinicaltrials.gov
November 4, 2026	NCT07915323	PET Imaging of the sigma1 Receptor in Healthy Adults	Yale University	Phase 1	Recruiting	Healthy Control Subjects	30	United States	clinicaltrials.gov
November 4, 2026	NCT07915297	Safety and Biodistribution of [68Ga]Ga DOTA-5G in Subjects With Metastatic Breast Cancer (BC)	Luminance Biosciences Inc	Phase 1	Not yet recruiting	Metastatic Breast Cancer	10	Australia	clinicaltrials.gov
November 4, 2026	NCT07915245	A Study of LY4247147 in Participants With Obesity or Overweight Who Are Otherwise Healthy	Eli Lilly and Company	Phase 1	Not yet recruiting	Obesity, Overweight	108	Singapore, United States	clinicaltrials.gov
November 4, 2026	NCT07915024	Phase 1 Study to Assess the Effects of HSK31858 on the QT/QTc Interval in Healthy Chinese Participants	Haisco Pharmaceutical Group Co., Ltd.	Phase 1	Recruiting	Non-cystic Fibrosis Bronchiectasis (NCFBE)	47	China	clinicaltrials.gov
November 4, 2026	NCT07915011	Investigation of Pharmacokinetics, Safety of HSK31858 in Subjects With Renal Impairment	Haisco Pharmaceutical Group Co., Ltd.	Phase 1	Recruiting	Non-cystic Fibrosis Bronchiectasis (NCFBE)	24	China	clinicaltrials.gov
November 4, 2026	NCT07914738	A Study of Lepodisiran (LY3819469) in Participants With High Lipoprotein(a)	Eli Lilly and Company	Phase 1	Not yet recruiting	Lipoprotein(a)	66		clinicaltrials.gov
November 3, 2026	NCT07914556	Phase 1 Study of 6MW5311 in Adults With Relapsed or Refractory Blood Cancers	Mabwell (Shanghai) Bioscience Co., Ltd.	Phase 1	Recruiting	AML, Multiple Myeloma, CMML	122	China	clinicaltrials.gov
November 3, 2026	NCT07914387	Stanford University Neurofiber Study	Stanford University	Phase 1	Not yet recruiting	PARKINSON DISEASE (Disorder)	50	United States	clinicaltrials.gov
November 3, 2026	NCT07914348	Evaluation of LB-208 (HTR1B Antagonist) in Adult Patients With Relapsed or Refractory Solid Tumours and Lymphoma	Leukos Biotech S.L.	Phase 1	Recruiting	Solid Tumor Malignancies, Lymphoma	57	Spain	clinicaltrials.gov
November 3, 2026	NCT07914244	Clinical Study of the Tolerability, Reactogenicity, and Safety of PoliovacSin in Volunteers Aged 18-60 Years	Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products	Phase 1	Completed	Poliomyelitis Vaccines	60	Russia	clinicaltrials.gov
November 3, 2026	NCT07914166	Asciminib-Based Induction Therapy for the Treatment of Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia	City of Hope Medical Center	Phase 1	Not yet recruiting	B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1	21	United States	clinicaltrials.gov
November 3, 2026	NCT07913672	A Study of LBP-MARCO and Ruxolitinib in People With Graft-Versus-Host Disease (GVHD)	Memorial Sloan Kettering Cancer Center	Phase 1	Recruiting	Transplant Failure or Rejection of Bone Marrow (Graft vs Host Disease, GVHD)	16	United States	clinicaltrials.gov
November 3, 2026	NCT07913282	ARTEMIS: UC-MSCs After Mechanical Thrombectomy for Acute Ischemic Stroke	Royan Stem Cell Technology Company	Phase 1	Not yet recruiting	Acute Ischemic Stroke	10	Iran	clinicaltrials.gov
November 3, 2026	NCT07913048	A Study to Evaluate the PK/PD and Safety of KL0011034 Injection in Healthy Non-Elderly and Elderly Trial Participants	Hunan Kelun Pharmaceutical Co., Ltd.	Phase 1	Not yet recruiting	Healthy Participants	20	China	clinicaltrials.gov
November 3, 2026	NCT07913009	Investigation of Pharmacokinetics, Safety of HSK31858 in Subjects With Hepatic Impairment	Haisco Pharmaceutical Group Co., Ltd.	Phase 1	Recruiting	Non-cystic Fibrosis Bronchiectasis (NCFBE)	30	China	clinicaltrials.gov
November 3, 2026	NCT07912840	Bioequivalence Study Between YHP2508B and YHR2602 in Healthy Subjects	Yuhan Corporation	Phase 1	Recruiting	Healthy Subjects (HS)	44	South Korea	clinicaltrials.gov
November 3, 2026	NCT07912827	Bioequivalence Study Between YHP2508A and YHR2601 in Healthy Subjects	Yuhan Corporation	Phase 1	Recruiting	Healthy Subjects (HS)	44	South Korea	clinicaltrials.gov
November 3, 2026	NCT07912268	Study of SIM0518 in Participants With ALK-Positive or ROS1-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer	Jiangsu Simcere Pharmaceutical Co., Ltd.	Phase 1	Not yet recruiting	ALK-Positive or ROS1-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer	270	China	clinicaltrials.gov
November 3, 2026	NCT07911982	Safety, Tolerability and Pharmacokinetics of ICP-B161 in Healthy Adults Volunteers	Beijing InnoCare Pharma Tech Co., Ltd.	Phase 1	Not yet recruiting	Inflammatory Bowel Disease(IBD)	88		clinicaltrials.gov
November 3, 2026	NCT07911943	Comparison of Analgesic Efficacy Between Ultrasound Guided Serratus Anterior Plane Block or Thoracic Paravertebral Block Versus Intravenous...	Ain Shams University	Phase 1	Active not recruiting	Intra and Post Operative Pain Management, Fast Track Program,(Enhanced Recovery After Surgery (ERAS))	111	Egypt	clinicaltrials.gov
November 2, 2026	NCT07911514	A Trial to Assess the Relative Bioavailability of Different Subcutaneous Formulations of AZD9550 and AZD6234	AstraZeneca	Phase 1	Not yet recruiting	Healthy Participants	60	United Kingdom	clinicaltrials.gov
November 2, 2026	NCT07911293	Intratumoral Chlorine Dioxide Injection in Advanced Solid Tumors	SunGlow Innovations LLC	Phase 1	Not yet recruiting	Solid Tumor, Neoplasms	50		clinicaltrials.gov
November 2, 2026	NCT07910942	A Phase 1 Trial of KAN-001 With Pembrolizumab, With or Without Chemotherapy, in Participants With PD-L1-Positive Non-Small Cell Lung Cancer	Kanvas Biosciences	Phase 1	Not yet recruiting	Non-Small Cell Lung Cancer	40	Canada, United States	clinicaltrials.gov
November 2, 2026	NCT07910708	GN001 for Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma and B-Cell Acute Lymphoblastic Leukemia	Department of Hematology,Rheumatology and Immunology,Pu'er People's Hospital	Phase 1	Recruiting	Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma, Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia	42	China	clinicaltrials.gov
November 2, 2026	NCT07910682	Bioequivalence of Sitagliptin/Metformin Tablets in Healthy Chinese Adults Under Fasting and Fed Conditions	Guangzhou Panyu Central Hospital	Phase 1	Completed	Healhty	56	China	clinicaltrials.gov
November 2, 2026	NCT07909837	A Phase 1 Clinical Trial of NTQ6179 Tablets in Healthy Volunteers	Nanjing Chia-tai Tianqing Pharmaceutical	Phase 1	Recruiting	Acromegaly	56	China	clinicaltrials.gov
November 2, 2026	NCT07909811	Novel endOvascular Therapy With beVAcizumab and Cannabinoids for Glioblastoma	Unity Health Toronto	Phase 1	Not yet recruiting	GBM	6		clinicaltrials.gov
November 2, 2026	NCT07909733	Maintenance Treatment With Imetelstat in Patients With High-Risk Myeloid Neoplasms After Allo-SCT	University of Wisconsin, Madison	Phase 1	Not yet recruiting	High-risk Myeloid Malignancy, Allogenic Stem Cell Transplantation, Acute Myeloid Leukemia (AML), Chronic Myeloid...	27	United States	clinicaltrials.gov
November 2, 2026	NCT07909434	A Study of Mesothelin-Targeted CAR-Mix Cells in Patients With Advanced Solid Tumors	Zhejiang University	Phase 1	Not yet recruiting	Mesothelin-Positive Advanced Solid Tumors With Peritoneal Metastasis	10		clinicaltrials.gov
November 2, 2026	NCT07909356	A Study of MC001 in Patients With Advanced or Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) and Other Folate Receptor Alpha...	Medicovestor, Inc	Phase 1	Not yet recruiting	Pancreatic Ductal Adenocarcinoma (PDAC), Advanced Solid Tumor Cancer, Metastatic Pancreatic Cancer, Metastatic Solid...	40	United States	clinicaltrials.gov
November 2, 2026	NCT07909070	A Study to Investigate the Pharmacokinetics of JMKX003142 in Healthy Participants and Participants With Hepatic Impairment	Jemincare	Phase 1	Not yet recruiting	ADPKD (Autosomal Dominant Polycystic Kidney Disease), Renal Edema	32		clinicaltrials.gov
November 2, 2026	NCT07908680	A Study to Assess the Safety, Tolerability and Pharmacokinetics of XEP527 in Patients With Stable Schizophrenia	Novartis Pharmaceuticals	Phase 1	Recruiting	Schizophrenia	36	United States	clinicaltrials.gov
November 2, 2026	NCT07908667	A Study of TRB191 in Patients With Extensive-stage Small Cell Lung Cancer	Novartis Pharmaceuticals	Phase 1	Not yet recruiting	Extensive-stage Small Cell Lung Cancer	120		clinicaltrials.gov
November 2, 2026	NCT07908641	Comparing the Extent to Which Apremilast is Made Available in the Body After Administration as an Extended-release or Immediate-release...	Amgen	Phase 1	Not yet recruiting	Psoriasis, Arthritis, Psoriatic, Oral Ulcer	114		clinicaltrials.gov
November 2, 2026	NCT07908316	Comparing the Extent to Which Maridebart Cafraglutide is Made Available in the Body of Participants Living With Overweight or Obesity After...	Amgen	Phase 1	Recruiting	Obesity, Overweight	180	United States	clinicaltrials.gov
October 30, 2026	NCT07908134	Study to Establish Safety, Tolerability and Pharmacokinetics of NRL-1049 in Healthy Adult Participants Following Multiple-Dose...	Neurelis, Inc.	Phase 1	Not yet recruiting	Cerebral Cavernous Malformation	40		clinicaltrials.gov
October 30, 2026	NCT07908004	A Study to Test How Well Different Doses of BI 3821001 Are Tolerated by Healthy People	Boehringer Ingelheim	Phase 1	Not yet recruiting	Healthy	40	Germany	clinicaltrials.gov
October 30, 2026	NCT07907172	Expanded Donor Stem Cells for Poor Graft Function After Stem Cell Transplantation in Children	wang xiaodong	Phase 1	Not yet recruiting	Poor Graft Function, Hematopoietic Stem Cell Transplantation Complications	3		clinicaltrials.gov
October 30, 2026	NCT07906691	A Study to Assess the Effect of Itraconazole on the Pharmacokinetics of HRS-4642 Following Intravenous Infusion in Healthy Participants	Shanghai Hengrui Pharmaceutical Co., Ltd.	Phase 1	Not yet recruiting	Pancreatic Cancer	18	China	clinicaltrials.gov
October 30, 2026	NCT07906665	A Study of Single Ascending Doses of NI112 in Adults With Amyotrophic Lateral Sclerosis (ALS)	Sachi Bioworks Inc.	Phase 1	Not yet recruiting	Amyotrophic Lateral Sclerosis (ALS)	40	United States	clinicaltrials.gov
October 30, 2026	NCT07906197	A Mass Balance Study on [14C]Levornidazole Disodium Phosphate for Injection in Healthy Chinese Adult Male Subjects	Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd	Phase 1	Completed	Mass Balance Study	6	China	clinicaltrials.gov
October 30, 2026	NCT07906171	Pharmacokinetics and Safety of Levornidazole Disodium Phosphate for Injection in Chinese Patients With Hepatic Impairment	Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd	Phase 1	Completed	Hepatic Impairment	25	China	clinicaltrials.gov
October 30, 2026	NCT07906145	A Phase 1 Study of QLS2416 Injection in Participants With Autoimmune Diseases	Shanghai Qilu Pharmaceutical Research and Development Center LTD	Phase 1	Not yet recruiting	Systemic Lupus Erythematosus, Rheumatoid Arthritis (RA), Primary Sjögren's Syndrome (pSS), Systemic Sclerosis (SSc)	76		clinicaltrials.gov
October 30, 2026	NCT07906080	Study to Evaluate the Feasibility and Safety of Autologous Cytokine-Induced Killer Cells (CIK_D332) in Combination With Tafasitamab and...	Istituto Oncologico Veneto IRCCS	Phase 1	Not yet recruiting	Diffuse Large B-Cell Lymphoma (DLBCL)	14	Italy	clinicaltrials.gov
October 30, 2026	NCT07905976	Safety and Tolerability of Single and Repeated Dose of IMM02-KORA in PD-associated Dyskinesia	Immunis, Inc.	Phase 1	Not yet recruiting	Dyskinesia, Medication-induced, Dyskinesia, Drug-Induced	15		clinicaltrials.gov
October 30, 2026	NCT07905924	A Study to Evaluate the Safety and Effectiveness of Different Doses of RO7836748 Alone or in Combination With Other Cancer Therapies in...	Hoffmann-La Roche	Phase 1	Not yet recruiting	Solid Tumors	540		clinicaltrials.gov
October 29, 2026	NCT07905677	Phase 1 Study of VT-101 in Advanced Ovarian Cancer	Michael J. Goodheart	Phase 1	Recruiting	Epithelial Ovarian Cancer, Ovarian Cancer	22	United States	clinicaltrials.gov
October 29, 2026	NCT07905560	A Study of Safety of SUN-0864 and How it is Processed by and Affects the Body in Healthy Adults and Healthy Adults Who Are Overweight or...	Superluminal Medicines, Inc.	Phase 1	Not yet recruiting	Healthy Participants	138		clinicaltrials.gov
October 29, 2026	NCT07905157	A Study to Compare Blood Levels of Bepirovirsen and Safety Using Different Methods of Injecting in Healthy Adult Participants	GlaxoSmithKline	Phase 1	Not yet recruiting	Hepatitis B	98		clinicaltrials.gov
October 29, 2026	NCT07905053	A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Food Effect of CBT-248 in Healthy Adult Participants	Cibus Therapeutics, Inc.	Phase 1	Recruiting	Chronic Pancreatitis	32	Australia	clinicaltrials.gov
October 29, 2026	NCT07905027	A Study of CLEC2A CAR T for Pediatric and Adult Patients With Relapsed or Refractory AML	Seattle Children's Hospital	Phase 1	Not yet recruiting	Acute Myeloid Leukemia, Acute Myeloid Leukaemia Recurrent, Acute Myeloid Leukaemia Refractory	20	United States	clinicaltrials.gov

Sponsors posting most

Sponsor	New trials	Latest
Merck Sharp & Dohme LLC	96	November 6, 2026
Eli Lilly and Company	92	November 5, 2026
Pfizer	83	October 29, 2026
AstraZeneca	80	November 2, 2026
Boehringer Ingelheim	62	November 9, 2026
Novo Nordisk A/S	57	October 26, 2026
AbbVie	56	November 9, 2026
M.D. Anderson Cancer Center	39	October 28, 2026
National Institute of Allergy and Infectious Diseases (NIAID)	37	September 14, 2026
West China Hospital	37	August 13, 2026
GlaxoSmithKline	33	October 29, 2026
Bristol-Myers Squibb	32	October 21, 2026
Jiangsu HengRui Medicine Co., Ltd.	32	August 12, 2026
City of Hope Medical Center	30	November 9, 2026
Amgen	30	November 6, 2026
Novartis Pharmaceuticals	29	November 6, 2026
Institute of Hematology & Blood Diseases Hospital, China	29	September 18, 2026
Jiangsu Hansoh Pharmaceutical Co., Ltd.	28	October 27, 2026
Haisco Pharmaceutical Group Co., Ltd.	27	November 6, 2026
Qilu Pharmaceutical Co., Ltd.	27	October 6, 2026

Conditions

Condition group	New trials	Latest
Obesity	205	November 9, 2026
Overweight	155	November 9, 2026
Carcinoma, Non-Small-Cell Lung	130	November 6, 2026
Neoplasms	117	November 6, 2026
Colorectal Neoplasms	111	October 29, 2026
Diabetes Mellitus, Type 2	100	October 26, 2026
Recurrence	90	November 6, 2026
Leukemia, Myeloid, Acute	89	November 6, 2026
Breast Neoplasms	88	November 6, 2026
Neoplasm Metastasis	81	October 29, 2026
Lupus Erythematosus, Systemic	79	November 6, 2026
Prostatic Neoplasms	67	October 22, 2026
Multiple Myeloma	65	November 3, 2026
Ovarian Neoplasms	62	November 6, 2026
Squamous Cell Carcinoma of Head and Neck	55	October 27, 2026
Pancreatic Neoplasms	50	November 2, 2026
Stomach Neoplasms	48	November 6, 2026
Lung Neoplasms	48	November 2, 2026
Dermatitis, Atopic	46	November 6, 2026
Carcinoma, Hepatocellular	46	October 6, 2026
Arthritis, Rheumatoid	44	November 6, 2026
Glioblastoma	43	October 7, 2026
Lymphoma, B-Cell	42	November 2, 2026
Alzheimer Disease	40	October 27, 2026
Renal Insufficiency	39	November 9, 2026

By country

Country	New trials	Latest
United States	1,928	November 9, 2026
China	1,543	November 9, 2026
Australia	354	November 9, 2026
South Korea	229	November 9, 2026
United Kingdom	157	November 5, 2026
Germany	153	October 30, 2026
Canada	152	November 5, 2026
Spain	130	November 9, 2026
Japan	101	November 9, 2026
France	89	October 16, 2026
Netherlands	84	October 19, 2026
Egypt	74	November 6, 2026
Belgium	66	October 14, 2026
New Zealand	62	November 9, 2026
Taiwan	47	October 29, 2026
Italy	41	October 30, 2026
India	37	October 13, 2026
Brazil	33	September 17, 2026
Pakistan	32	August 5, 2026
Denmark	31	August 18, 2026
Singapore	29	November 4, 2026
Israel	28	October 19, 2026
Russia	27	November 3, 2026
Poland	27	October 14, 2026
Switzerland	26	September 24, 2026

Where the register publishes

U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.